≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Nightmares

Endpoint Browser PheWeb

F5_NIGHTMARES

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F51.5
  • Cause of death: ICD-10 — F51.5

2 out of 7 registries used, show all original rules.

75

4. Check minimum number of events

None

75

5. Include endpoints

None

75

6. Filter based on genotype QC (FinnGen only)

75

Control definitions (FinnGen only)

Control exclude
F5_SLEEP

Extra metadata

First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 528 298 223
Only index persons 483 282 201
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 30.77 29.91 31.65
Only index persons 31.02 29.91 32.57

-FinnGen-

Key figures

All Female Male
Number of individuals 75 56 19
Unadjusted period prevalence (%) 0.02 0.02 0.01
Median age at first event (years) 43.79 36.41 65.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
65
Matched controls
651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F51.5
ICD-10 Finland
Nightmares
+∞
93.3
65
*
N05AH04
ATC
quetiapine; oral
10.7
15.3
34
60
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
+∞
12.9
12
*
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
144.6
11.8
12
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
27.2
11.3
15
7
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
23.8
10.9
15
8
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
18.8
10.7
16
11
N04BC05
ATC
pramipexole; oral
19.4
9.5
14
9
N06AX11
ATC
mirtazapine; oral
5.2
9.1
38
138
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
32.5
8.8
11
*
F51.0
ICD-10 Finland
Nonorganic insomnia
6.8
8.6
23
48
IEY18
NOMESCO Finland
Psychiatric sleep coaching, individual
+∞
8.5
8
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
15.9
8.3
13
10
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
7.8
7.0
16
26
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
19.3
7.0
10
6
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
19.3
7.0
10
6
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
11.9
6.9
12
12
N06AX16
ATC
venlafaxine; oral
5.2
6.9
23
62
F43.1
ICD-10 Finland
Post-traumatic stress disorder
16.6
6.6
10
7
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
11.0
6.6
12
13
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
20.5
6.5
9
5
N03AE01
ATC
clonazepam; systemic
11.7
6.3
11
11
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
7.8
6.3
14
22
ZY010
NOMESCO Finland
Hospital outpatient
9.5
6.2
12
15
N06AX05
ATC
trazodone; oral
17.1
6.1
9
6
N05AH03
ATC
olanzapine; systemic
12.8
6.0
10
9

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
29
6.22
7.82
1.3
1.4
mg/l
4.3
3.5
0.12
15
16
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
42
187
3.83
7.65
2.7
2.8
u/l
22.5
25.9
0.95
42
176
(3022948) Iron [Moles/volume] in Serum or Plasma
23
74
4.04
6.57
2.2
1.8
umol/l
14.3
15.6
0.28
23
69
(3028707) Methadone [Presence] in Urine by Screen method
12
24
5.76
5.97
2.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
7
14.37
5.74
1.9
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
39
198
3.02
5.25
2.4
1.8
pmol/l
97.5
93.2
0.23
19
109
(3015736) pH of Urine
42
228
2.91
4.92
4.1
3.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
43
4.11
4.91
3.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
43
4.11
4.91
3.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
43
4.11
4.91
3.0
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
43
4.11
4.91
3.0
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
42
231
2.86
4.75
6.2
6.2
mmol/l
1.2
1.2
0.07
37
194
(3011288) Drugs identified in Urine by Screen method
12
30
4.57
4.64
3.2
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
41
3.97
4.43
3.1
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
53
341
2.89
4.28
3.1
2.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
60
415
3.23
4.20
5.7
4.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
34
180
2.63
3.98
3.9
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
52
339
2.74
3.96
8.0
8.7
e9/l
4.1
4.1
0.06
44
304
(3035350) Ketones [Presence] in Urine by Test strip
45
280
2.52
3.68
3.8
3.4
estimate
0.0
0.0
—
10
53
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
36
3.78
3.65
2.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
136
2.54
3.42
6.4
7.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
7
9.18
3.32
1.2
1.0
—
—
—
0
0
(3012544) pH of Venous blood
10
28
3.97
3.32
3.2
3.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
10
28
3.97
3.32
3.2
3.5
kpa
6.2
5.6
—
10
28
(3021601) Nitrite [Presence] in Urine by Test strip
44
280
2.38
3.30
5.2
4.9
estimate
0.0
0.0
—
10
53
(3018095) Leukocytes [#/volume] in Urine
35
203
2.36
3.23
4.8
3.5
e6/l
68.6
44.6
0.17
23
130
(3012516) Albumin [Mass/volume] in Urine
23
110
2.57
3.22
3.0
3.1
mg/l
9.1
76.7
1.52
14
64
(3000494) Fungus identified in Specimen by Culture
15
58
2.98
3.10
1.7
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
31
177
2.28
2.91
3.1
2.9
ng/l
15.5
27.7
1.25
18
99
(3019309) Folate [Moles/volume] in Red Blood Cells
18
80
2.64
2.89
1.6
1.6
nmol/l
1140.3
1236.0
0.15
13
63
(3009261) Glucose [Presence] in Urine by Test strip
43
284
2.20
2.81
4.0
3.5
estimate
0.0
0.0
—
10
52
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
69
2.68
2.71
1.1
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
36
225
2.15
2.66
1.9
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
33
3.34
2.64
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
23
121
2.30
2.57
3.1
3.7
mg/mmol
1.0
11.3
1.90
14
68
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
27
3.64
2.49
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
28
163
2.15
2.44
4.0
3.1
e6/l
27.1
435.6
0.52
22
125
(1002224) Polysomnography panel
8
22
3.94
2.44
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
26
147
2.18
2.44
4.4
3.7
estimate
0.0
0.0
—
9
51
(36304419) Bacteria [Presence] in Urine
26
148
2.16
2.39
3.7
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
60
2.64
2.39
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
34
215
2.06
2.38
3.7
3.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
68
575
2.95
2.30
5.1
3.7
mmol/l
2.7
2.8
0.57
63
532
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
67
568
2.68
2.22
4.4
3.5
mmol/l
4.4
4.7
2.10
61
531
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
14
4.56
2.19
1.5
4.2
%
1.1
1.2
—
6
14
(3003327) Ova and parasites identified in Stool by Light microscopy
8
25
3.45
2.16
1.8
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
15
4.25
2.08
1.5
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
26
3.32
2.08
4.6
9.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
23
132
2.07
2.04
4.0
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
25
149
2.02
2.00
3.7
2.7
e6/l
1.2
0.3
0.36
18
112
(42870588) Differential panel, method unspecified - Blood
29
183
1.95
1.98
5.1
5.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
16
3.98
1.97
1.5
3.9
g/l
137.5
124.2
—
6
16
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
95
2.18
1.96
1.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
65
544
2.46
1.93
14.1
10.2
ml/min/173m2
90.4
91.1
0.12
57
433
(3013512) EKG study
22
128
2.02
1.87
3.8
3.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
66
564
2.42
1.84
4.6
3.5
mmol/l
1.4
1.5
1.35
61
524
(3021589) Normoblasts [#/volume] in Blood
36
250
1.85
1.81
10.5
8.0
e9/l
0.0
0.0
0.00
28
213
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
30
2.86
1.78
2.0
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
7
24
3.11
1.77
3.3
3.7
kpa
4.3
4.6
—
7
24
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
51
2.36
1.59
1.6
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
15
3.49
1.55
1.2
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
59
2.23
1.53
3.4
2.3
u/l
2128.5
960.8
—
6
19
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
162
1.81
1.52
2.2
2.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
38
2.55
1.52
2.7
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
15
82
2.04
1.49
3.5
2.5
ng/l
6.7
137.0
—
10
41
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
98
1.95
1.46
2.2
2.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
5
16
3.27
1.46
1.4
4.6
mmol/l
25.8
24.4
—
5
16
(3048689) Calprotectin [Mass/mass] in Stool
17
99
1.93
1.42
2.5
2.2
ug/g
56.1
70.7
0.22
17
76
(3032080) INR in Blood by Coagulation assay
26
174
1.76
1.41
3.1
6.1
inr
1.0
1.1
—
9
59
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
17
3.07
1.38
1.6
1.3
%
90.8
97.1
—
5
17
(3026008) Bacteria identified in Urine by Culture
25
172
1.68
1.21
2.8
2.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
58
2.05
1.19
1.7
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
157
1.67
1.14
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
58
498
1.73
1.14
4.1
3.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
41
2.06
1.12
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
9
45
2.13
1.10
4.7
4.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
85
1.80
1.03
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
23
162
1.61
1.00
3.4
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
86
1.77
0.99
2.1
1.6
pmol/l
324.2
461.0
2.08
14
76
(4010399)
7
37
1.98
0.97
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
63
1.87
0.96
4.8
5.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
79
1.78
0.95
2.7
2.4
e6/l
4.4
3.1
—
6
42
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
20
138
1.61
0.94
2.0
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
56
1.91
0.93
2.8
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
18
123
1.61
0.88
4.7
3.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
24
0.00
0.81
0.0
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
25
0.00
0.80
0.0
2.3
—
3.3
—
0
17
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
27
0.00
0.79
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
144
1.53
0.79
2.0
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
23
2.25
0.78
1.4
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
76
1.69
0.77
4.1
4.2
%
21.0
22.2
—
5
37
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
24
2.16
0.76
1.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
85
1.64
0.75
2.7
2.2
e6/l
0.7
0.7
—
6
48
(3019060) Gas panel - Arterial blood
5
25
2.07
0.74
2.2
5.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
297
1.41
0.71
3.7
3.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
44
1.65
0.67
1.0
1.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
24
188
1.41
0.62
2.2
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
162
1.41
0.58
1.7
1.3
u/ml
0.6
2.2
—
7
35
(3000492) Spirometry study
9
60
1.57
0.57
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
18
136
1.43
0.56
5.7
4.9
—
—
—
0
0
(3002256) Pathology report gross observation
9
63
1.49
0.55
1.2
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
75
1.55
0.54
1.5
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
7
45
1.61
0.50
2.7
3.4
%
1.7
1.8
—
7
38
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
46
1.57
0.50
1.6
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
46
1.57
0.50
3.1
3.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
80
0.60
0.49
1.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
48
1.50
0.48
1.0
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
7
49
1.47
0.47
6.6
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
19
151
1.35
0.44
1.5
1.3
g/l
2.1
2.4
0.31
12
93
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
15
0.00
0.41
0.0
2.2
—
122.0
—
0
6
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
15
189
0.74
0.41
1.9
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
115
0.66
0.40
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
13
164
0.75
0.35
1.5
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
56
524
1.27
0.33
22.7
13.4
%
13.0
13.5
3.73
56
519
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
21
179
1.24
0.29
2.3
1.7
—
—
—
0
0
(4035726)
5
40
1.27
0.23
1.6
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
42
1.20
0.22
1.2
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
42
1.20
0.22
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4094501)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
14
118
1.23
0.21
1.4
1.3
u/ml
1.1
5.9
—
6
44
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
66
0.74
0.18
1.6
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
66
0.74
0.18
1.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
66
0.74
0.18
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
66
0.74
0.18
1.6
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
69
0.71
0.17
1.6
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
20
220
0.88
0.14
1.6
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
220
0.88
0.14
2.1
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
73
1.11
0.08
1.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
59
577
1.11
0.07
18.2
11.4
%
40.4
40.3
0.17
47
467
(3050129) First trimester maternal screen panel - Serum or Plasma
7
80
0.86
0.07
1.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
104
0.85
0.07
1.2
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
22
223
0.98
0.00
2.3
2.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
13
129
1.01
0.00
2.3
2.8
umol/l
335.3
3336.2
0.49
13
107
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
90.1
—
0
8
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
2.5
—
0
9
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.8
—
0
5
(3011985) Renin [Units/volume] in Plasma
0
9
0.00
0.00
0.0
1.1
—
31.7
—
0
9
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
585.0
—
0
5
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
90
1.00
0.00
1.6
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
70
1.00
0.00
1.3
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2110.0
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
7.0
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
54
0.92
0.00
1.6
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
6.6
—
2542.7
—
0
9
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.5
—
164.8
—
0
6
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
2.1
—
0
5
(3005033) Fetal Nuchal fold Thickness US
5
54
0.92
0.00
1.6
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
1.7
—
91.0
—
0
7
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
0.2
—
0
5
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.3
—
105.4
—
0
7
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
56
0.89
0.00
1.6
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_NIGHTMARES and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_NIGHTMARES.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: F5_NIGHTMARES – Nightmares

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data